# FDA 483 - Biovectra, Inc. - February 17, 2017

Source: https://www.globalkeysolutions.net/records/483/biovectra-inc/773a5858-5c4c-456e-bdf5-e703c5faaff7

> FDA 483 for Biovectra, Inc. on February 17, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Biovectra, Inc.
- Inspection Date: 2017-02-17
- Product Type: drugs
- Office Name: Office of Pharmaceutical Quality

## Related Documents

- [483 - 2022-08-26](https://www.globalkeysolutions.net/records/483/biovectra-inc/a9e6f5c1-5f2f-405e-8e41-a3422f6d1306)
- [483 - 2024-04-19](https://www.globalkeysolutions.net/records/483/biovectra-inc/f876d21b-ffcd-4001-af36-2c6b587572d0)

## Related Officers

- [Chemist](https://www.globalkeysolutions.net/people/tonya-r-johnson/403d3eb6-758b-4c57-80cf-901359382588)
- [Account Director](https://www.globalkeysolutions.net/people/stacie-a-woods/75a78a01-422e-4c6a-b7ac-b858354264ae)

Company: https://www.globalkeysolutions.net/companies/biovectra-inc/1e29a998-319e-49cb-bee2-bacea2c620ef

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality/c3303908-9657-4cd3-ae43-2458c98e8a64